Page last updated: 2024-09-04

vatalanib and zm 336372

vatalanib has been researched along with zm 336372 in 1 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(zm 336372)
Trials
(zm 336372)
Recent Studies (post-2010) (zm 336372)
276429827011

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)zm 336372 (IC50)
Receptor-interacting serine/threonine-protein kinase 2Homo sapiens (human)100
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.0603
Proto-oncogene tyrosine-protein kinase LCK Mus musculus (house mouse)0.57
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.23
Delta-type opioid receptorMus musculus (house mouse)0.18
Mitogen-activated protein kinase 11Homo sapiens (human)2
Mitogen-activated protein kinase 14Homo sapiens (human)1.09

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1

Other Studies

1 other study(ies) available for vatalanib and zm 336372

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007